Can methyldopa be used safely in patients with end-stage renal disease (ESRD) and what adjustments to dosage or monitoring are required?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Methyldopa can be used in ESRD, but dosage reduction is necessary. Typically, dosages are adjusted based on renal function and patient response to avoid hypotension. Regular BP monitoring is advised.